ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

N4P N4 Pharma Plc

0.575
-0.025 (-4.17%)
03 Dec 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
N4 Pharma Plc LSE:N4P London Ordinary Share GB00BYW8QM32 ORD 0.4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.025 -4.17% 0.575 0.55 0.60 0.60 0.575 0.60 907,070 10:27:50
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Drug & Proprietary Stores 2k -1.27M -0.0032 -1.78 2.37M
N4 Pharma Plc is listed in the Drug & Proprietary Stores sector of the London Stock Exchange with ticker N4P. The last closing price for N4 Pharma was 0.60p. Over the last year, N4 Pharma shares have traded in a share price range of 0.412p to 1.40p.

N4 Pharma currently has 394,780,000 shares in issue. The market capitalisation of N4 Pharma is £2.37 million. N4 Pharma has a price to earnings ratio (PE ratio) of -1.78.

N4 Pharma Share Discussion Threads

Showing 8476 to 8497 of 8675 messages
Chat Pages: 347  346  345  344  343  342  341  340  339  338  337  336  Older
DateSubjectAuthorDiscuss
21/2/2024
08:40
>> Fydo

You say the Nanogenics product is ‘months away’ from clinical trials. That is not what the announcement on 16th January said so do you have inside information from Nigel?!?

I presume you know when it says ‘in vivo study’ that means animal model experiments….

nobbygnome
21/2/2024
08:34
You're obviously pretty interested.. It's a shame you choose this path every time, I think featherby's request is reasonable and would be respected.
dplewis1
21/2/2024
07:30
Could real D.Farrier set up a twitter profile? Introduce, share research and explain your investment and reasonings.

I genuinely think everyone would welcome this.

featherby81
20/2/2024
22:51
dplewis1,
Neither am I you idiot but there are plenty that are down and you revel in that do you.
You are seriously sick.

fydo
20/2/2024
22:45
I'm not the one several hundred grand down on a company rapidly running out of cash .. moron
dplewis1
20/2/2024
22:41
dplewis1, the last three Nuvec releases have proven to be highly positive. Only a paid basher would consider it to be a duffer.
You have a serious mental issue. I would feel sorry for you if it wasn't for the fact that you are a complete idiot.

fydo
20/2/2024
22:24
dplewis1,
The difference is you halfwit, these are clinical trials. Even someone as "clueless" as you should be able appreciate the difference between clinical and pre clinical because the market certainty will.

fydo
20/2/2024
21:57
That's the latest thing Nigel has sold you on is it Dave .. another pre-clinical dream to get you to cough up for the next placing. He's great at dangling the carrot isn't he..
dplewis1
20/2/2024
21:05
And it’s funny how blatant misinformed ramping is perfectly acceptable to Fydo…..but rational informed criticism is not! Further hypocrisy….
nobbygnome
20/2/2024
21:02
Fydo how about you misrepresenting my words earlier today with a description of Nigel I have never written. Hypocrite is the appropriate word….
nobbygnome
20/2/2024
20:32
Same old Dave, weaseling out of it.. posting that commercialisation is months away is still material information if it's true. Nigel won't be happy but you've got a bit of a fractious relationship these days I believe
dplewis1
20/2/2024
20:25
dplewis1,
So you admit to misrepresenting my words and making a deliberate attempt to cause trouble between David Farrier (I checked) and Nigel.
Absolutely despicable.
Your insane fixation with that gentleman is obviously some sort of mental illness.
Once again when Pinky comes out to play then so does Perky. One could almost believe you were working together.
Just out of interest, does being a share basher pay well.
The pair of you should be ashamed of yourselves.

fydo
20/2/2024
19:59
That’s a classic. And he berates us for calling this correctly all the way down from 30p….unbelievable!
nobbygnome
20/2/2024
19:40
"You can almost smell a deal on Viagra while multiple deals on Nuvec are close and yet we are still under 30p. Incredible"That's a post from you from almost 6 years ago.. still posting the same twaddle. And you think I'm challenged..
dplewis1
20/2/2024
19:35
I know Nigel shares my frustration with your aliases on bulletin boards David. For someone so well acquainted with the company you just know the name is spelt Farrier .. but I suppose it's still your pitiful attempt to pretend it's not you.
dplewis1
20/2/2024
19:30
So what has Nigel told you Fydo? Don’t be shy…
nobbygnome
20/2/2024
18:37
dplewis1.
I am begining to think you are truly challenged. You need to understand the difference between commercialisation and a commercial deal,
In effect a deal could be signed at anytime as you don't necessarily have to be in clinic to sign a deal and with a MTA still in place and who knows what other interest, a deal could come at any time. However, it is generally accepted that commercialisation is more likely to be when the product is proven in clinical trials. At that point commercialisation occurs meaning that it is a proven product and a commercial deal could follow. It is that commercialisation that is months away.
I saw your post on the investment hub and I consider it to be a direct attempt to get David Farriar into trouble with Nigel.
You are clearly a person with serious problems.

fydo
20/2/2024
17:56
I asked a question on the investor site, seems like Dave telling porkies again "i cannot comment on speculation from any shareholder as to what they or others are posting on bulletin boards"
dplewis1
20/2/2024
15:30
So Fydo since you clearly have information about ongoing deal discussions from Nigel perhaps you can share it with us here so we can all be on a level playing field….
nobbygnome
20/2/2024
10:18
It doesn't need a scientist to ask the question of why Nuvec has been left on the shelf for so long. Big pharma snap up promising tech (GSK bought Aiolos Bio recently and that company was only incorporated in 2023) so why do the much vaunted MTA partners kick the tyres and never commit. If Nuvec was going to impact delivery systems then N4 would have been swallowed up a long time ago
dplewis1
20/2/2024
07:59
Commercialisation is months away is it.. and you know this for a fact do you?
dplewis1
20/2/2024
07:53
LOLOLOLOLOLOL watch that blood pressure!

Please point to the post where I have said ‘Nigel is a lying conman’ or that ‘Nuvec doesn’t work’? You throw out unsubstantiated statements and should be careful. You see I am a scientist and look at the evidence. There is currently no data which says that Nuvec will work in humans and so the jury is out. When we get further evidence, I will assess it and amend my opinion accordingly.

The bottom line is the company has spent lots of money on in vitro experiments and animal models which haven’t got them very far. Substantial risks remain which is the nature of science but due to your ramping you underplay those risks

nobbygnome
Chat Pages: 347  346  345  344  343  342  341  340  339  338  337  336  Older